Fungal respiratory tract infection detection by nucleic acid amplification probe (lower respiratory specimen)

What This Test Measures

The test uses a genetic probe to identify specific fungal DNA sequences present in your lower respiratory tract. This is done through a nucleic acid amplification process, which amplifies and detects fungal genetic material that may indicate an infection caused by fungi such as *Candida* or *Aspergillus*. The probe is designed to target regions unique to fungal organisms, helping differentiate fungal infections from other causes of respiratory symptoms.

How the Test Works

The test involves collecting a sample from your lower respiratory tract (e.g., sputum or fluid obtained via bronchoscopy). The sample is then processed to extract genetic material. A specialized probe binds to fungal DNA sequences, and the test detects and quantifies these sequences using amplification techniques. This process is highly sensitive and specific for fungal pathogens.

Why It Might Be Ordered

Your healthcare provider may order this test if you have symptoms suggestive of a fungal lung infection, such as persistent cough, chest pain, fever, or difficulty breathing, especially if you have a weakened immune system, recent lung procedures, or risk factors like diabetes or HIV. It is particularly useful in diagnosing infections that may not respond to standard antibiotics.

When Results May Be Abnormal

Abnormal results typically indicate the presence of fungal DNA in your respiratory tract, suggesting a fungal infection. However, false positives can occur if the sample contains non-infectious fungal material or if contamination is present. False negatives may happen if the fungal load is too low to detect or if the sample was not collected properly.